Welcome to the world’s leading series of cold chain life science events…now in Miami!
The total revenue generated by the Latin American pharmaceutical industry is expected to exceed $85M by 2018. Combined with the booming global development of biologic-based drugs and personalized therapies, the LATAM life science supply chain continues to grow in both size and complexity. With so much investment at stake, maintaining product integrity and complying with Good Distribution Practices (GDPs) is more important now than ever before.
Last year’s conference stressed the importance of maintaining strong quality agreements to establish accountability and improve relationships with supply chain partners. Attendees also took advantage of our exhibit hall featuring the industry’s leading solution providers to compare and contrast the latest cutting edge solutions. Another major highlight was the extensive networking available both through interactive small-group discussions and onsite mixers.
For this year’s bilingual conference, we’re recruiting the industry’s leading minds who’ll provide end-to-end strategies on how to implement sound risk-management practices to determine the most cost-efficient mode of transporting your product…without sacrificing product quality.